Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial-Reference-Cited by-同舟云学术

Effect of valve design and anticoagulation strategy on 30-day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial

Published:2017-07-19 Issue:6 Volume:90 Page:1016-1026
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Linke Axel¹,Chandrasekhar Jaya²^ORCID,Sartori Samantha²,Lefevre Thierry³,van Belle Eric⁴,Schaefer Ulrich⁵⁶,Tchetche Didier⁷,Sardella Gennaro⁸,Webb John⁹,Colombo Antonio¹⁰,Windecker Stephan¹¹,Vogel Birgit²,Farhan Serdar²,Sorrentino Sabato²,Sharma Madhav²,Snyder Clayton²,Asgar Anita¹²,Dumonteil Nicolas⁷,Tamburino Corrado¹³,Hink Ulrich¹⁴,Violini Roberto¹⁵,Stella Pieter¹⁶,Bernstein Debra¹⁷,Deliargyris Efthymios¹⁷,Hengstenberg Christian¹⁸¹⁹^ORCID,Baber Usman²,Mehran Roxana²,Anthopoulos Prodromos²⁰,Dangas George²^ORCID,

Affiliation:

1. Department of Internal Medicine/Cardiology; University of Leipzig, Heart Centre; Germany

2. Division of Cardiology; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai; New York

3. Division of Cardiology; Institut Hospitalier Jacques Cartier, Ramsay Générale de Santé; Massy France

4. Department of Cardiology and INSERM UMR 1011; University Hospital, and CHRU Lille; Lille France

5. Division of Cardiologyy; University Heart Center; Hamburg Germany

6. Division of Cardiologyy; Asklepios Clinics St. Georg; Hamburg Germany

7. Division of Cardiologyy; Clinique Pasteur Toulouse; France

8. Division of Cardiologyy; Policlinico Umberto I; Rome Italy

9. Division of Cardiologyy; St. Paul's Hospital; Vancouver British Columbia Canada

10. Division of Cardiologyy; San Raffaele Hospital; Milan Italy

11. Department of Cardiology; Bern University Hospital; Switzerland

12. Division of Cardiology; Montreal Heart Institute; Montreal Canada

13. Division of Cardiology; University of Catania; Italy

14. Cardiology Department; Johannes Gutenberg University Hospital; Mainz Germany

15. Division of Cardiology; Azienda Ospedaliera San Camillo-Forlanini di Roma; Italy

16. Division of Cardiology; University Medical Center Utrecht; The Netherlands

17. Division of Cardiology; The Medicines Company; Parsippany New Jersey

18. Division of Cardiology; DZHK (German Centre for Cardiovascular Research), partner site Munich Heart Alliance; Munich Germany

19. Division of Cardiologyy; Deutsches Herzzentrum München, Technische Universität München; Munich Germany

20. Division of Cardiology; The Medicines Company; Zurich Switzerland

Funder

The Medicines Company

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Reference41 articles.

1. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery;Leon;N Engl J Med,2010

2. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients;Leon;N Engl J Med,2016

3. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients;Reardon;N Engl J Med,2017

4. ACC Expert Consensus Decision Pathway for Transcatheter Aortic Valve Replacement in the Management of Adults With Aortic Stenosis: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents;Otto;J Am Coll Cardiol,2017

5. Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: A propensity score analysis;Thourani;Lancet,2016

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety and efficacy of balloon-expandable versus self-expanding trans-catheter aortic valve replacement in high-risk patients with severe symptomatic aortic stenosis;Frontiers in Cardiovascular Medicine;2023-05-25

2. Neuroprotective measures throughout the TAVI pathway;Minerva Cardioangiologica;2019-01

3. Use of Bivalirudin for Anticoagulation in Interventional Cardiovascular Procedures;Cardiovascular Innovations and Applications;2018-07-01

4. Stroke After Transcatheter Aortic Valve Replacement: Incidence, Definitions, Etiologies and Management Options;Journal of Cardiothoracic and Vascular Anesthesia;2018-04